Design and discovery of 1,4-dihydropyrimidinone-based noncovalent DprE1 inhibitors with integrated biological and computational validation against Mycobacterium tuberculosis.

PubMed 1970-01-01 added 2026-07-23

Fayek FH, Mousa MHA, Said MF, Georgey HH, Abdel Gawad NM